Holen Sie sich die Stockscreener-App
4.82
0.42%
0.02
Finanzdaten der Endra Life Sciences Inc-Aktie (NDRA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
31.77%
1.4833
|
2.1737 | 1.622 | 1.3707 | 1.3011 |
| Operating Income/Loss |
31.77%
-1.4833
|
-2.1737 | -1.622 | -1.3707 | -1.3011 |
| Nonoperating Income/Loss |
90.56%
1.6432
|
0.8623 | -1.5472 | -0.2253 | - |
| Income/Loss From Continuing Operations Before Tax |
112.20%
0.1599
|
-1.3114 | -3.1692 | -1.596 | -1.2259 |
| Net Income/Loss |
112.20%
0.1599
|
-1.3114 | -3.1692 | -1.596 | -1.2259 |
| Basic Average Shares |
10.38%
1.324
|
1.1996 | - | 0.7612 | - |
| Diluted Average Shares |
106.34%
2.4753
|
1.1996 | - | 0.7612 | - |
| Basic Earnings Per Share |
111.01%
0.12
|
-1.09 | - | -2.10 | - |
| Diluted Earnings Per Share |
105.50%
0.06
|
-1.09 | - | -2.10 | - |
10.48%
13.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):